CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 27 enrolled
Drug / intervention
Insulindrug
Likely dose
Insulin 110mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00779701
NCT00779701Phase 4Completed
CompareCT.gov

Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation

Temple University·interventional·Posted Oct 24, 2008·Updated Mar 16, 2017

In Brief

A Phase 4 clinical trial evaluating Insulin for Hyperglycemia. Completed, enrolled 27 participants across 1 site.

Detailed Summary

Glycemic control can be safely achieved in surgical and medical intensive care unit settings and has been shown to improve short and long-term clinical outcomes. As such, insulin infusion protocols are routinely used in the ICU setting. The investigators plan to establish the use of strict glycemic control in a heterogenous group of acutely ill patients in the ED setting. The investigators propose to study the aspects of implementing a strict glycemic control protocol in the ED.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 24, 2008
Enrollment StartMar 1, 2007
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 17.7 years ago

Interventions

Insulindrug

Insulin infusion titrated to patients blood glucose to maintain blood glucose between 80-110mg/dL